Emergent Biosolutions reported $217.5M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Akebia Therapeutics AKBA:US $ 7.8M 36.58M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Amarin AMRN:US $ 30.21M 1.94M
Ani Pharmaceuticals ANIP:US $ 24.41M 2.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Coherus Biosciences CHRS:US $ 21.28M 4.58M
Emergent Biosolutions EBS:US $ 217.5M 10.3M
Exact Sciences EXAS:US $ 115.74M 1.77M
Exelixis EXEL:US $ 11.87M 3.01M
Flexion Therapeutics FLXN:US $ 3.73M 1.25M
Glaxosmithkline GSK:US $ 2822M 303M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Ironwood Pharmaceuticals IRWD:US $ 0M 0M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Lexicon Pharmaceuticals LXRX:US $ 0M 0M
Lonza Group LONN:SW 1.5B 690M
Merk MRK:US $ 3056M 14M
Moderna Inc MRNA:US 722M 28M
Myriad Genetics MYGN:US $ 47.8M 5.9M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Opko Health OPK:US $ 243.96M 48.95M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Pfizer PFE:US $ 9931M 2939M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Seattle Genetics SGEN:US $ 82.65M 4.56M
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
United Therapeutics UTHR:US $ 27.7M 9.5M
Vanda Pharmaceuticals VNDA:US $ 6.8M 0.23M